3,6-Dichloropyridazine → HCID 86720116, compound
Reaction equation
[CH3:1][O:2][C:3](=[O:26])[CH2:4][C@H:5]1[C:9]2[CH:10]=[CH:11][C:12]([O:14][C@H:15]3[C:23]4[C:18](=[C:19]([OH:25])[CH:20]=[CH:21][C:22]=4[F:24])[CH2:17][CH2:16]3)=[CH:13][C:8]=2[O:7][CH2:6]1.[Cl:27][C:28]1[N:29]=[N:30][C:31](Cl)=[CH:32][CH:33]=1>>[CH3:1][O:2][C:3](=[O:26])[CH2:4][C@H:5]1[C:9]2[CH:10]=[CH:11][C:12]([O:14][C@H:15]3[C:23]4[C:18](=[C:19]([O:25][C:31]5[N:30]=[N:29][C:28]([Cl:27])=[CH:33][CH:32]=5)[CH:20]=[CH:21][C:22]=4[F:24])[CH2:17][CH2:16]3)=[CH:13][C:8]=2[O:7][CH2:6]1Participants
3
Procedure
The title compound is prepared from {(S)-6-[(R)-7-fluoro-4-hydroxy-indan-1-yloxy]-2,3-dihydro-benzofuran-3-yl}-acetic acid methyl ester and 3,6-dichloro-pyridazine following a procedure analogous to that described for Intermediate 12. LC (method 2): tR=1.11 min; Mass spectrum (ESI+): m/z=471/473 (Cl) [M+H]+.
Sources & evidence
- ORD record
- ord-9ddae79562684d5dbea346a890cb9f51
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08815864B2
Reaction notes
Loading…